346 Results for:

November 17, 2022

United States
Will Biden’s Trade Policy Shift after the Midterms?

It probably won’t, and that would be a mistake.

U.S. Trade Representative Katherine Tai testifies before a Senate Finance Committee hearing on President Biden's trade policy agenda on Capitol Hill in Washington, D.C.

July 1, 2013

Asia
Emerging Voices: Jessica Seddon on Do-It-Yourself Governance in India

Emerging Voices features regular contributions from scholars and practitioners highlighting new research, thinking, and approaches to development challenges. This article is from Jessica Seddon, foun…

RTR3AX7I

November 10, 2022

Defense and Security
Happy 247th Birthday to the United States Marine Corps!

The United States Marine Corps marks 247 years of service. 

Marine Corps Sgt. Anthony T. Ruiz

November 10, 2022

Defense and Security
Happy 247th Birthday to the United States Marine Corps!

The United States Marine Corps marks 247 years of service. 

Marine Corps Sgt. Anthony T. Ruiz on a training exercise

July 31, 2017

Cybersecurity
An Open Letter to Thomas Chandler, a Sub-Par Cybercriminal

If an online deal is too good to be true, it's probably a scam.

Cottage on Moosehead Lake

March 26, 2013

Sub-Saharan Africa
Emerging Voices: Callan, Blak, and Thomas on China’s Foreign Aid and Investment

Emerging Voices features regular contributions from scholars and practitioners highlighting new research, thinking, and approaches to development challenges. This article is from Paul Callan, Jasmin …

dalberg funding graphic 2

June 22, 2012

Americas
New from CFR: Thomas Bollyky on the Rio+20 Conference

In an interview today on CFR.org, CFR Senior Fellow Thomas Bollyky discusses the environmental and development issues on the table at the Rio+20 Conference. Bollyky suggests that the conference’s ult…

bollyky-rio-brazil-ministerial

September 24, 2012

Health
New From CFR: Thomas Bollyky on Noncommunicable Diseases

In a CFR.org interview last week timed to the one-year anniversary of a UN high-level meeting on the subject, CFR senior fellow Thomas Bollyky discussed global progress on combating noncommunicable d…

thomas_bollyky_noncommunicable_diseases_china_respiratory

April 11, 2013

Asia
New From CFR: Thomas Bollyky on Drug Patents in the Developing World

In light of an Indian court’s refusal to grant a patent to the leukemia drug Gleevec, CFR senior fellow Thomas Bollyky wrote yesterday about the tension between pharmaceutical firms seeking compensat…

gleevec india pharmaceuticals

November 6, 2022

Israel
Israel's Election: What to Think About Religious Zionists, Netanyahu, and Tales of Doomsday

Doomsday predictions about the consequences of Israel's election are overwrought. Some of the proposed legal reforms would bring Israel's system closer to the U.S. model.